PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study) - Imperial College London (ClinicalTrials.gov, 2024)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com